世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
バイオリンクに関する市場調査。天然バイオインクの需要は驚異的な高水準で推移Market Study on Bioinks: Demand for Natural Bioinks to Remain Incredibly High バイオリンクス市場レポート対象範囲 Persistence Market Research社が発行した世界のバイオインク市場に関する最新刊は、機会や現在の市場展望を評価し、市場に影響を与える対応するセクションに関する詳細な... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーバイオリンクス市場レポート対象範囲Persistence Market Research社が発行した世界のバイオインク市場に関する最新刊は、機会や現在の市場展望を評価し、市場に影響を与える対応するセクションに関する詳細な分析と最新情報を提供しています。この調査は、市場の促進要因、抑制要因、傾向、機会を含む現在の市場力学に関する詳細な洞察を提供します。市場調査の主な目的は、市場が2022年から2032年の予測期間中にどのように推移するかについての独占的な情報を提示することです。 市場の成功成長のための重要な指標は、この包括的なレポートで提示されており、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）など、Persistence Market Research社の調査において網羅的に記述されています。この調査研究は、バイオリンク市場製品の需要と調査期間中の定量的な開発機会を知るために読者をサポートすることができます。 この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、バイオリンク市場で繁栄するための適切なビジネス戦略の開発に役立てることができます。このPersistence Market Researchの調査で提示された洞察と情報は、バイオリンク市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家が活用することができます。 市場統計だけでなく、バイオリンク市場のビジネスシナリオに影響を与えるマクロだけでなく、マクロ経済変数にリンクされた情報も、現在の研究に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートで遭遇します。さらに、このレポートで提出されたデータによって、業界のマイナーな企業や新規参入者は、市場で牽引力を得るために適切な会社の選択をする際に支援されることができます。 主要な市場セグメント Persistence Market Researchのバイオインク市場に関する調査では、材料、ソース、印刷モダリティ、アプリケーション、臓器/ヒト組織、エンドユーザー、地域の7つの重要なセグメントに分けられた情報を提供しています。本レポートでは、これらのカテゴリに関連する重要な市場力学と成長パラメータに関する包括的なデータおよび情報を提供しています。 材料 アガロース アルギン酸 キトサン コラーゲン フィブリノーゲン ゼラチン ヒアルロン酸 グラフェン ハイドロキシアパタイト 細胞・組織由来ECM ジアクリル酸ポリ（エチレングリコール）（PEGDA） その他 出典 天然 合成 印刷方式 押出成形によるバイオプリンティング インクジェットバイオプリンティング レーザーベースバイオプリンティング 応用分野 組織工学と再生医療 組織移植 医薬品・ハイスループットスクリーニング 臓器・人体組織 ヒト耳 腎臓 肝臓 心臓 皮膚 軟骨 骨 幹細胞 血管 がん研究 肺 筋肉 その他 エンドユーザー 医療機器メーカー 製薬会社 研究機関・学術機関 受託研究機関 地域別 北アメリカ ラテンアメリカ 欧州 南アジア 東アジア オセアニア MEA 報告書に記載されている主な質問 今後数年間、バイオリンクの最も収益性の高い市場であり続けるのはどの地域か？ トレンドの変化は市場にどのような影響を与えるか？ COVID-19危機は市場の成長にどのような影響を与えたか？ 市場参加者はどのようにして先進地域の低空飛行の機会を捕らえることができるのか？ 市場におけるステークホルダーの戦略はどのようなものですか？ 投資家が認識する必要があり、市場への投資中に取り組む可能性がある抑制要因は何か？ 市場に影響を与える開発動向は？ バイオリンク市場の企業は、どのようにして先進国および新興国の成長機会を利用することができるのか？ 調査方法 Persistence Market Research社の調査では、バイオリンク市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論を得るために、独自の調査手法を活用しています。この調査手法は、一次調査と二次調査を組み合わせたものであり、アナリストが結論の正確性と信頼性を確保するのに役立つものです。 市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、バイオインク市場の成長見通しに関するPersistence Market Researchの予測をより正確で信頼性の高いものにしています。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technological Advancements 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions & Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption/Usage Analysis 4.2. Regulatory Landscape 4.3. PESTEL Analysis 4.4. Porter’s Analysis 4.5. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Increasing Investments in R&D Activities 5.2.3. Product Penetration Rate across End Users 5.2.4. Usage of Bioinks in Research Institutes 5.2.5. Percentage of New Sales of Bioinks 5.2.6. New/Improved Product Launches 5.2.7. Technological Advancements 5.2.8. Prevalence of Infectious Diseases 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. Revenue By Material 6.1.2. Revenue By Source 6.1.3. Revenue By Printing Modality 6.1.4. Revenue By Application 6.1.5. Revenue By Organ/Human Tissue 6.1.6. Revenue By End User 6.1.7. Revenue By Country 6.2. 2021 Market Scenario 7. Global Bioinks Market Demand Volume (Units) Analysis 2017 –2021 and Forecast, 2022–2032 7.1. Historical Market Volume (Units) Analysis, 2017 –2021 7.2. Current and Future Market Volume (Units) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Bioinks Market - Pricing Analysis 8.1. Regional Pricing Analysis By-Product 8.2. Pricing Break Up 8.2.1. Manufacturer Level 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Bioinks Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, By Material 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Material, 2017–2021 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Material, 2022–2032 10.3.1. Agarose 10.3.2. Alginate 10.3.3. Chitosan 10.3.4. Collagen 10.3.5. Fibrinogen 10.3.6. Gelatin 10.3.7. Hyaluronic Acid (HA) 10.3.8. Graphene 10.3.9. Hydroxyapatite 10.3.10. Cell- and Tissue- derived ECM 10.3.11. Poly(ethylene glycol) diacrylate (PEGDA) 10.3.12. Others 10.4. Market Attractiveness Analysis By Material 11. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Material 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Material, 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Material, 2022–2032 11.3.1. Natural 11.3.2. Synthetic 11.4. Market Attractiveness Analysis By Material 12. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Printing Modality 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By Printing Modality, 2017–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Printing Modality, 2022–2032 12.3.1. Extrusion-based Bioprinting 12.3.2. Inkjet-based Bioprinting 12.3.3. Laser-based Bioprinting 12.4. Market Attractiveness Analysis By Printing Modality 13. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Application 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Analysis By Application, 2017–2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032 13.3.1. Tissue Engineering & Regenerative Medicine 13.3.2. Tissue Transplantation 13.3.3. Pharmaceuticals and High-throughput screening 13.4. Market Attractiveness Analysis By Application 14. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, By Organ/Human Tissue 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Analysis By Organ/Human Tissue, 2017–2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Organ/Human Tissue, 2022–2032 14.3.1. Human Ear 14.3.2. Kidney 14.3.3. Liver 14.3.4. Heart 14.3.5. Skin 14.3.6. Cartilage 14.3.7. Bones 14.3.8. Stem cell 14.3.9. Blood vessels 14.3.10. Cancer Research 14.3.11. Lungs 14.3.12. Muscles 14.3.13. Others 14.4. Market Attractiveness Analysis By Organ/Human Tissue 15. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by End User 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 15.3.1. Medical Device Manufacturers 15.3.2. Pharmaceutical Companies 15.3.3. Research & Academic Institutions 15.3.4. Contract Research Organizations 15.4. Market Attractiveness Analysis By End User 16. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Region 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2017–2021 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032 16.3.1. North America 16.3.2. Latin America 16.3.3. Europe 16.3.4. East Asia 16.3.5. South Asia 16.3.6. Oceania 16.3.7. Middle East and Africa (MEA) 16.4. Market Attractiveness Analysis By Region 17. North America Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 17.4.1. By Country 17.4.1.1. U.S. 17.4.1.2. Canada 17.4.2. By Material 17.4.3. By Source 17.4.4. By Printing Modality 17.4.5. By Application 17.4.6. By Organ/Human Tissue 17.4.7. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Material 17.5.3. By Source 17.5.4. By Printing Modality 17.5.5. By Application 17.5.6. By Organ/Human Tissue 17.5.7. By End User 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Market Trends 17.9. Country Level Analysis & Forecast 17.9.1. U.S. Bioinks Market 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Material 17.9.1.2.2. By Source 17.9.1.2.3. By Printing Modality 17.9.1.2.4. By Application 17.9.1.2.5. By Organ/Human Tissue 17.9.1.2.6. By End User 17.9.2. Canada Bioinks Market 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Material 17.9.2.2.2. By Source 17.9.2.2.3. By Printing Modality 17.9.2.2.4. By Application 17.9.2.2.5. By Organ/Human Tissue 17.9.2.2.6. By End User 18. Latin America Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 18.4.1. By Country 18.4.1.1. Brazil 18.4.1.2. Mexico 18.4.1.3. Argentina 18.4.1.4. Rest of Latin America 18.4.2. By Material 18.4.3. By Source 18.4.4. By Printing Modality 18.4.5. By Application 18.4.6. By Organ/Human Tissue 18.4.7. By End User 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Material 18.5.3. By Source 18.5.4. By Printing Modality 18.5.5. By Application 18.5.6. By Organ/Human Tissue 18.5.7. By End User 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Market Trends 18.9. Country Level Analysis & Forecast 18.9.1. Brazil Bioinks Market 18.9.1.1. Introduction 18.9.1.2. Market Analysis and Forecast by Market Taxonomy 18.9.1.2.1. By Material 18.9.1.2.2. By Source 18.9.1.2.3. By Printing Modality 18.9.1.2.4. By Application 18.9.1.2.5. By Organ/Human Tissue 18.9.1.2.6. By End User 18.9.2. Argentina Bioinks Market 18.9.2.1. Introduction 18.9.2.2. Market Analysis and Forecast by Market Taxonomy 18.9.2.2.1. By Material 18.9.2.2.2. By Source 18.9.2.2.3. By Printing Modality 18.9.2.2.4. By Application 18.9.2.2.5. By Organ/Human Tissue 18.9.2.2.6. By End User 18.9.3. Mexico Bioinks Market 18.9.3.1. Introduction 18.9.3.2. Market Analysis and Forecast by Market Taxonomy 18.9.3.2.1. By Material 18.9.3.2.2. By Source 18.9.3.2.3. By Printing Modality 18.9.3.2.4. By Application 18.9.3.2.5. By Organ/Human Tissue 18.9.3.2.6. By End User 19. Europe Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 19.4.1. By Country 19.4.1.1. Germany 19.4.1.2. UK 19.4.1.3. France 19.4.1.4. Italy 19.4.1.5. Spain 19.4.1.6. Russia 19.4.1.7. BENELUX 19.4.1.8. Nordic Countries 19.4.1.9. Rest of Europe 19.4.2. By Material 19.4.3. By Source 19.4.4. By Printing Modality 19.4.5. By Application 19.4.6. By Organ/Human Tissue 19.4.7. By End User 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Material 19.5.3. By Source 19.5.4. By Printing Modality 19.5.5. By Application 19.5.6. By Organ/Human Tissue 19.5.7. By End User 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Market Trends 19.9. Country Level Analysis & Forecast 19.9.1. Germany Bioinks Market 19.9.1.1. Introduction 19.9.1.2. Market Analysis and Forecast by Market Taxonomy 19.9.1.2.1. By Material 19.9.1.2.2. By Source 19.9.1.2.3. By Printing Modality 19.9.1.2.4. By Application 19.9.1.2.5. By Organ/Human Tissue 19.9.1.2.6. By End User 19.9.2. France Bioinks Market 19.9.2.1. Introduction 19.9.2.2. Market Analysis and Forecast by Market Taxonomy 19.9.2.2.1. By Material 19.9.2.2.2. By Source 19.9.2.2.3. By Printing Modality 19.9.2.2.4. By Application 19.9.2.2.5. By Organ/Human Tissue 19.9.2.2.6. By End User 19.9.3. Italy Bioinks Market 19.9.3.1. Introduction 19.9.3.2. Market Analysis and Forecast by Market Taxonomy 19.9.3.2.1. By Material 19.9.3.2.2. By Source 19.9.3.2.3. By Printing Modality 19.9.3.2.4. By Application 19.9.3.2.5. By Organ/Human Tissue 19.9.3.2.6. By End User 19.9.4. Spain Bioinks Market 19.9.4.1. Introduction 19.9.4.2. Market Analysis and Forecast by Market Taxonomy 19.9.4.2.1. By Material 19.9.4.2.2. By Source 19.9.4.2.3. By Printing Modality 19.9.4.2.4. By Application 19.9.4.2.5. By Organ/Human Tissue 19.9.4.2.6. By End User 19.9.5. U.K. Bioinks Market 19.9.5.1. Introduction 19.9.5.2. Market Analysis and Forecast by Market Taxonomy 19.9.5.2.1. By Material 19.9.5.2.2. By Source 19.9.5.2.3. By Printing Modality 19.9.5.2.4. By Application 19.9.5.2.5. By Organ/Human Tissue 19.9.5.2.6. By End User 19.9.6. BENELUX Bioinks Market 19.9.6.1. Introduction 19.9.6.2. Market Analysis and Forecast by Market Taxonomy 19.9.6.2.1. By Material 19.9.6.2.2. By Source 19.9.6.2.3. By Printing Modality 19.9.6.2.4. By Application 19.9.6.2.5. By Organ/Human Tissue 19.9.6.2.6. By End User 19.9.7. Russia Bioinks Market 19.9.7.1. Introduction 19.9.7.2. Market Analysis and Forecast by Market Taxonomy 19.9.7.2.1. By Material 19.9.7.2.2. By Source 19.9.7.2.3. By Printing Modality 19.9.7.2.4. By Application 19.9.7.2.5. By Organ/Human Tissue 19.9.7.2.6. By End User 19.9.8. Nordic Countries Bioinks Market 19.9.8.1. Introduction 19.9.8.2. Market Analysis and Forecast by Market Taxonomy 19.9.8.2.1. By Material 19.9.8.2.2. By Source 19.9.8.2.3. By Printing Modality 19.9.8.2.4. By Application 19.9.8.2.5. By Organ/Human Tissue 19.9.8.2.6. By End User 20. South Asia Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 20.4.1. By Country 20.4.1.1. India 20.4.1.2. Thailand 20.4.1.3. Indonesia 20.4.1.4. Malaysia 20.4.1.5. Rest of South Asia 20.4.2. By Material 20.4.3. By Source 20.4.4. By Printing Modality 20.4.5. By Application 20.4.6. By Organ/Human Tissue 20.4.7. By End User 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Material 20.5.3. By Source 20.5.4. By Printing Modality 20.5.5. By Application 20.5.6. By Organ/Human Tissue 20.5.7. By End User 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Market Trends 20.9. Country Level Analysis & Forecast 20.9.1. India Bioinks Market 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Material 20.9.1.2.2. By Source 20.9.1.2.3. By Printing Modality 20.9.1.2.4. By Application 20.9.1.2.5. By Organ/Human Tissue 20.9.1.2.6. By End User 20.9.2. Indonesia Bioinks Market 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Material 20.9.2.2.2. By Source 20.9.2.2.3. By Printing Modality 20.9.2.2.4. By Application 20.9.2.2.5. By Organ/Human Tissue 20.9.2.2.6. By End User 20.9.3. Malaysia Bioinks Market 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Material 20.9.3.2.2. By Source 20.9.3.2.3. By Printing Modality 20.9.3.2.4. By Application 20.9.3.2.5. By Organ/Human Tissue 20.9.3.2.6. By End User 20.9.4. Thailand Bioinks Market 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Material 20.9.4.2.2. By Source 20.9.4.2.3. By Printing Modality 20.9.4.2.4. By Application 20.9.4.2.5. By Organ/Human Tissue 20.9.4.2.6. By End User 21. East Asia Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 21.1. Introduction 21.2. Pricing Analysis 21.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 21.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 21.4.1. By Country 21.4.1.1. China 21.4.1.2. Japan 21.4.1.3. South Korea 21.4.2. By Material 21.4.3. By Source 21.4.4. By Printing Modality 21.4.5. By Application 21.4.6. By Organ/Human Tissue 21.4.7. By End User 21.5. Market Attractiveness Analysis 21.5.1. By Country 21.5.2. By Material 21.5.3. By Source 21.5.4. By Printing Modality 21.5.5. By Application 21.5.6. By Organ/Human Tissue 21.5.7. By End User 21.6. Key Market Participants - Intensity Mapping 21.7. Drivers and Restraints - Impact Analysis 21.8. Market Trends 21.9. Country Level Analysis & Forecast 21.9.1. China Bioinks Market 21.9.1.1. Introduction 21.9.1.2. Market Analysis and Forecast by Market Taxonomy 21.9.1.2.1. By Material 21.9.1.2.2. By Source 21.9.1.2.3. By Printing Modality 21.9.1.2.4. By Application 21.9.1.2.5. By Organ/Human Tissue 21.9.1.2.6. By End User 21.9.2. Japan Bioinks Market 21.9.2.1. Introduction 21.9.2.2. Market Analysis and Forecast by Market Taxonomy 21.9.2.2.1. By Material 21.9.2.2.2. By Source 21.9.2.2.3. By Printing Modality 21.9.2.2.4. By Application 21.9.2.2.5. By Organ/Human Tissue 21.9.2.2.6. By End User 21.9.3. South Korea Bioinks Market 21.9.3.1. Introduction 21.9.3.2. Market Analysis and Forecast by Market Taxonomy 21.9.3.2.1. By Material 21.9.3.2.2. By Source 21.9.3.2.3. By Printing Modality 21.9.3.2.4. By Application 21.9.3.2.5. By Organ/Human Tissue 21.9.3.2.6. By End User 22. Oceania Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 22.1. Introduction 22.2. Pricing Analysis 22.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 22.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 22.4.1. By Country 22.4.1.1. Australia 22.4.1.2. New Zealand 22.4.2. By Material 22.4.3. By Source 22.4.4. By Printing Modality 22.4.5. By Application 22.4.6. By Organ/Human Tissue 22.4.7. By End User 22.5. Market Attractiveness Analysis 22.5.1. By Country 22.5.2. By Material 22.5.3. By Source 22.5.4. By Printing Modality 22.5.5. By Application 22.5.6. By Organ/Human Tissue 22.5.7. By End User 22.6. Key Market Participants - Intensity Mapping 22.7. Drivers and Restraints - Impact Analysis 22.8. Market Trends 22.9. Country Level Analysis & Forecast 22.9.1. Australia Bioinks Market 22.9.1.1. Introduction 22.9.1.2. Market Analysis and Forecast by Market Taxonomy 22.9.1.2.1. By Material 22.9.1.2.2. By Source 22.9.1.2.3. By Printing Modality 22.9.1.2.4. By Application 22.9.1.2.5. By Organ/Human Tissue 22.9.1.2.6. By End User 22.9.2. New Zealand Bioinks Market 22.9.2.1. Introduction 22.9.2.2. Market Analysis and Forecast by Market Taxonomy 22.9.2.2.1. By Material 22.9.2.2.2. By Source 22.9.2.2.3. By Printing Modality 22.9.2.2.4. By Application 22.9.2.2.5. By Organ/Human Tissue 22.9.2.2.6. By End User 23. Middle East and Africa (MEA) Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 23.1. Introduction 23.2. Pricing Analysis 23.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 23.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 23.4.1. By Country 23.4.1.1. GCC Countries 23.4.1.2. Turkey 23.4.1.3. South Africa 23.4.1.4. Rest of Middle East and Africa 23.4.2. By Material 23.4.3. By Source 23.4.4. By Printing Modality 23.4.5. By Application 23.4.6. By Organ/Human Tissue 23.4.7. By End User 23.5. Market Attractiveness Analysis 23.5.1. By Country 23.5.2. By Material 23.5.3. By Source 23.5.4. By Printing Modality 23.5.5. By Application 23.5.6. By Organ/Human Tissue 23.5.7. By End User 23.6. Key Market Participants - Intensity Mapping 23.7. Drivers and Restraints - Impact Analysis 23.8. Country Level Analysis & Forecast 23.8.1. GCC Countries Bioinks Market 23.8.1.1. Introduction 23.8.1.2. Market Analysis and Forecast by Market Taxonomy 23.8.1.2.1. By Material 23.8.1.2.2. By Source 23.8.1.2.3. By Printing Modality 23.8.1.2.4. By Application 23.8.1.2.5. By Organ/Human Tissue 23.8.1.2.6. By End User 23.8.2. Turkey Bioinks Market 23.8.2.1. Introduction 23.8.2.2. Market Analysis and Forecast by Market Taxonomy 23.8.2.2.1. By Material 23.8.2.2.2. By Source 23.8.2.2.3. By Printing Modality 23.8.2.2.4. By Application 23.8.2.2.5. By Organ/Human Tissue 23.8.2.2.6. By End User 23.8.3. South Africa Bioinks Market 23.8.3.1. Introduction 23.8.3.2. Market Analysis and Forecast by Market Taxonomy 23.8.3.2.1. By Material 23.8.3.2.2. By Source 23.8.3.2.3. By Printing Modality 23.8.3.2.4. By Application 23.8.3.2.5. By Organ/Human Tissue 23.8.3.2.6. By End User 24. Market Structure Analysis 24.1. Market Analysis by Tier of Companies 24.2. Market Share Analysis of Top Players 24.3. Market Concentration 24.4. Market Presence Analysis 24.4.1. Regional Footprint Analysis 24.4.2. Product Footprint Analysis 24.4.3. Channel Footprint Analysis 25. Competition Analysis 25.1. Competition Dashboard 25.2. Competition Benchmarking 25.3. Competition Deep Dive 25.3.1. (BICO GROUP AB) CELLINK 25.3.1.1. Overview 25.3.1.2. Product Portfolio 25.3.1.3. Key Financials 25.3.1.4. SWOT Analysis 25.3.1.5. Sales Footprint 25.3.1.6. Strategy Overview 25.3.1.7. Key Developments 25.3.1.7.1. Marketing Strategies 25.3.1.7.2. Product Strategies 25.3.1.7.3. Channel Strategies 25.3.2. Merck KGaA 25.3.2.1. Overview 25.3.2.2. Product Portfolio 25.3.2.3. Key Financials 25.3.2.4. SWOT Analysis 25.3.2.5. Sales Footprint 25.3.2.6. Strategy Overview 25.3.2.7. Key Developments 25.3.2.7.1. Marketing Strategies 25.3.2.7.2. Product Strategies 25.3.2.7.3. Channel Strategies 25.3.3. Allevi, Inc. 25.3.3.1. Overview 25.3.3.2. Product Portfolio 25.3.3.3. Key Financials 25.3.3.4. SWOT Analysis 25.3.3.5. Sales Footprint 25.3.3.6. Strategy Overview 25.3.3.7. Key Developments 25.3.3.7.1. Marketing Strategies 25.3.3.7.2. Product Strategies 25.3.3.7.3. Channel Strategies 25.3.4. TheWell Bioscience Inc. 25.3.4.1. Overview 25.3.4.2. Product Portfolio 25.3.4.3. Key Financials 25.3.4.4. SWOT Analysis 25.3.4.5. Sales Footprint 25.3.4.6. Strategy Overview 25.3.4.7. Key Developments 25.3.4.7.1. Marketing Strategies 25.3.4.7.2. Product Strategies 25.3.4.7.3. Channel Strategies 25.3.5. CollPlant Biotechnologies Ltd. 25.3.5.1. Overview 25.3.5.2. Product Portfolio 25.3.5.3. Key Financials 25.3.5.4. SWOT Analysis 25.3.5.5. Sales Footprint 25.3.5.6. Strategy Overview 25.3.5.7. Key Developments 25.3.5.7.1. Marketing Strategies 25.3.5.7.2. Product Strategies 25.3.5.7.3. Channel Strategies 25.3.6. UPM Biomedicals 25.3.6.1. Overview 25.3.6.2. Product Portfolio 25.3.6.3. Key Financials 25.3.6.4. SWOT Analysis 25.3.6.5. Sales Footprint 25.3.6.6. Strategy Overview 25.3.6.7. Key Developments 25.3.6.7.1. Marketing Strategies 25.3.6.7.2. Product Strategies 25.3.6.7.3. Channel Strategies 25.3.7. Brinter® 25.3.7.1. Overview 25.3.7.2. Product Portfolio 25.3.7.3. Key Financials 25.3.7.4. SWOT Analysis 25.3.7.5. Sales Footprint 25.3.7.6. Strategy Overview 25.3.7.7. Key Developments 25.3.7.7.1. Marketing Strategies 25.3.7.7.2. Product Strategies 25.3.7.7.3. Channel Strategies 25.3.8. Foldink 25.3.8.1. Overview 25.3.8.2. Product Portfolio 25.3.8.3. Key Financials 25.3.8.4. SWOT Analysis 25.3.8.5. Sales Footprint 25.3.8.6. Strategy Overview 25.3.8.7. Key Developments 25.3.8.7.1. Marketing Strategies 25.3.8.7.2. Product Strategies 25.3.8.7.3. Channel Strategies 25.3.9. Black Drop Biodrucker Gmb 25.3.9.1. Overview 25.3.9.2. Product Portfolio 25.3.9.3. Key Financials 25.3.9.4. SWOT Analysis 25.3.9.5. Sales Footprint 25.3.9.6. Strategy Overview 25.3.9.7. Key Developments 25.3.9.7.1. Marketing Strategies 25.3.9.7.2. Product Strategies 25.3.9.7.3. Channel Strategies 25.3.10. TissueLabs 25.3.10.1. Overview 25.3.10.2. Product Portfolio 25.3.10.3. Key Financials 25.3.10.4. SWOT Analysis 25.3.10.5. Sales Footprint 25.3.10.6. Strategy Overview 25.3.10.7. Key Developments 25.3.10.7.1. Marketing Strategies 25.3.10.7.2. Product Strategies 25.3.10.7.3. Channel Strategies 25.3.11. Axolotl Biosciences 25.3.11.1. Overview 25.3.11.2. Product Portfolio 25.3.11.3. Key Financials 25.3.11.4. SWOT Analysis 25.3.11.5. Sales Footprint 25.3.11.6. Strategy Overview 25.3.11.7. Key Developments 25.3.11.7.1. Marketing Strategies 25.3.11.7.2. Product Strategies 25.3.11.7.3. Channel Strategies 25.3.12. Manchester BIOGEL 25.3.12.1. Overview 25.3.12.2. Product Portfolio 25.3.12.3. Key Financials 25.3.12.4. SWOT Analysis 25.3.12.5. Sales Footprint 25.3.12.6. Strategy Overview 25.3.12.7. Key Developments 25.3.12.7.1. Marketing Strategies 25.3.12.7.2. Product Strategies 25.3.12.7.3. Channel Strategies 25.3.13. 3DPL 25.3.13.1. Overview 25.3.13.2. Product Portfolio 25.3.13.3. Key Financials 25.3.13.4. SWOT Analysis 25.3.13.5. Sales Footprint 25.3.13.6. Strategy Overview 25.3.13.7. Key Developments 25.3.13.7.1. Marketing Strategies 25.3.13.7.2. Product Strategies 25.3.13.7.3. Channel Strategies 25.3.14. Humabiologics 25.3.14.1. Overview 25.3.14.2. Product Portfolio 25.3.14.3. Key Financials 25.3.14.4. SWOT Analysis 25.3.14.5. Sales Footprint 25.3.14.6. Strategy Overview 25.3.14.7. Key Developments 25.3.14.7.1. Marketing Strategies 25.3.14.7.2. Product Strategies 25.3.14.7.3. Channel Strategies 26. Assumptions and Acronyms Used 27. Research Methodology
SummaryBioinks Market: Scope of Report Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technological Advancements 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions & Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption/Usage Analysis 4.2. Regulatory Landscape 4.3. PESTEL Analysis 4.4. Porter’s Analysis 4.5. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Increasing Investments in R&D Activities 5.2.3. Product Penetration Rate across End Users 5.2.4. Usage of Bioinks in Research Institutes 5.2.5. Percentage of New Sales of Bioinks 5.2.6. New/Improved Product Launches 5.2.7. Technological Advancements 5.2.8. Prevalence of Infectious Diseases 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. Revenue By Material 6.1.2. Revenue By Source 6.1.3. Revenue By Printing Modality 6.1.4. Revenue By Application 6.1.5. Revenue By Organ/Human Tissue 6.1.6. Revenue By End User 6.1.7. Revenue By Country 6.2. 2021 Market Scenario 7. Global Bioinks Market Demand Volume (Units) Analysis 2017 –2021 and Forecast, 2022–2032 7.1. Historical Market Volume (Units) Analysis, 2017 –2021 7.2. Current and Future Market Volume (Units) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Bioinks Market - Pricing Analysis 8.1. Regional Pricing Analysis By-Product 8.2. Pricing Break Up 8.2.1. Manufacturer Level 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Bioinks Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, By Material 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Material, 2017–2021 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Material, 2022–2032 10.3.1. Agarose 10.3.2. Alginate 10.3.3. Chitosan 10.3.4. Collagen 10.3.5. Fibrinogen 10.3.6. Gelatin 10.3.7. Hyaluronic Acid (HA) 10.3.8. Graphene 10.3.9. Hydroxyapatite 10.3.10. Cell- and Tissue- derived ECM 10.3.11. Poly(ethylene glycol) diacrylate (PEGDA) 10.3.12. Others 10.4. Market Attractiveness Analysis By Material 11. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Material 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Material, 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Material, 2022–2032 11.3.1. Natural 11.3.2. Synthetic 11.4. Market Attractiveness Analysis By Material 12. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Printing Modality 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By Printing Modality, 2017–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Printing Modality, 2022–2032 12.3.1. Extrusion-based Bioprinting 12.3.2. Inkjet-based Bioprinting 12.3.3. Laser-based Bioprinting 12.4. Market Attractiveness Analysis By Printing Modality 13. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Application 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Analysis By Application, 2017–2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032 13.3.1. Tissue Engineering & Regenerative Medicine 13.3.2. Tissue Transplantation 13.3.3. Pharmaceuticals and High-throughput screening 13.4. Market Attractiveness Analysis By Application 14. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, By Organ/Human Tissue 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Analysis By Organ/Human Tissue, 2017–2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Organ/Human Tissue, 2022–2032 14.3.1. Human Ear 14.3.2. Kidney 14.3.3. Liver 14.3.4. Heart 14.3.5. Skin 14.3.6. Cartilage 14.3.7. Bones 14.3.8. Stem cell 14.3.9. Blood vessels 14.3.10. Cancer Research 14.3.11. Lungs 14.3.12. Muscles 14.3.13. Others 14.4. Market Attractiveness Analysis By Organ/Human Tissue 15. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by End User 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 15.3.1. Medical Device Manufacturers 15.3.2. Pharmaceutical Companies 15.3.3. Research & Academic Institutions 15.3.4. Contract Research Organizations 15.4. Market Attractiveness Analysis By End User 16. Global Bioinks Market Analysis 2017–2021 and Forecast 2022–2032, by Region 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2017–2021 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032 16.3.1. North America 16.3.2. Latin America 16.3.3. Europe 16.3.4. East Asia 16.3.5. South Asia 16.3.6. Oceania 16.3.7. Middle East and Africa (MEA) 16.4. Market Attractiveness Analysis By Region 17. North America Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 17.4.1. By Country 17.4.1.1. U.S. 17.4.1.2. Canada 17.4.2. By Material 17.4.3. By Source 17.4.4. By Printing Modality 17.4.5. By Application 17.4.6. By Organ/Human Tissue 17.4.7. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Material 17.5.3. By Source 17.5.4. By Printing Modality 17.5.5. By Application 17.5.6. By Organ/Human Tissue 17.5.7. By End User 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Market Trends 17.9. Country Level Analysis & Forecast 17.9.1. U.S. Bioinks Market 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Material 17.9.1.2.2. By Source 17.9.1.2.3. By Printing Modality 17.9.1.2.4. By Application 17.9.1.2.5. By Organ/Human Tissue 17.9.1.2.6. By End User 17.9.2. Canada Bioinks Market 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Material 17.9.2.2.2. By Source 17.9.2.2.3. By Printing Modality 17.9.2.2.4. By Application 17.9.2.2.5. By Organ/Human Tissue 17.9.2.2.6. By End User 18. Latin America Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 18.4.1. By Country 18.4.1.1. Brazil 18.4.1.2. Mexico 18.4.1.3. Argentina 18.4.1.4. Rest of Latin America 18.4.2. By Material 18.4.3. By Source 18.4.4. By Printing Modality 18.4.5. By Application 18.4.6. By Organ/Human Tissue 18.4.7. By End User 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Material 18.5.3. By Source 18.5.4. By Printing Modality 18.5.5. By Application 18.5.6. By Organ/Human Tissue 18.5.7. By End User 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Market Trends 18.9. Country Level Analysis & Forecast 18.9.1. Brazil Bioinks Market 18.9.1.1. Introduction 18.9.1.2. Market Analysis and Forecast by Market Taxonomy 18.9.1.2.1. By Material 18.9.1.2.2. By Source 18.9.1.2.3. By Printing Modality 18.9.1.2.4. By Application 18.9.1.2.5. By Organ/Human Tissue 18.9.1.2.6. By End User 18.9.2. Argentina Bioinks Market 18.9.2.1. Introduction 18.9.2.2. Market Analysis and Forecast by Market Taxonomy 18.9.2.2.1. By Material 18.9.2.2.2. By Source 18.9.2.2.3. By Printing Modality 18.9.2.2.4. By Application 18.9.2.2.5. By Organ/Human Tissue 18.9.2.2.6. By End User 18.9.3. Mexico Bioinks Market 18.9.3.1. Introduction 18.9.3.2. Market Analysis and Forecast by Market Taxonomy 18.9.3.2.1. By Material 18.9.3.2.2. By Source 18.9.3.2.3. By Printing Modality 18.9.3.2.4. By Application 18.9.3.2.5. By Organ/Human Tissue 18.9.3.2.6. By End User 19. Europe Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 19.4.1. By Country 19.4.1.1. Germany 19.4.1.2. UK 19.4.1.3. France 19.4.1.4. Italy 19.4.1.5. Spain 19.4.1.6. Russia 19.4.1.7. BENELUX 19.4.1.8. Nordic Countries 19.4.1.9. Rest of Europe 19.4.2. By Material 19.4.3. By Source 19.4.4. By Printing Modality 19.4.5. By Application 19.4.6. By Organ/Human Tissue 19.4.7. By End User 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Material 19.5.3. By Source 19.5.4. By Printing Modality 19.5.5. By Application 19.5.6. By Organ/Human Tissue 19.5.7. By End User 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Market Trends 19.9. Country Level Analysis & Forecast 19.9.1. Germany Bioinks Market 19.9.1.1. Introduction 19.9.1.2. Market Analysis and Forecast by Market Taxonomy 19.9.1.2.1. By Material 19.9.1.2.2. By Source 19.9.1.2.3. By Printing Modality 19.9.1.2.4. By Application 19.9.1.2.5. By Organ/Human Tissue 19.9.1.2.6. By End User 19.9.2. France Bioinks Market 19.9.2.1. Introduction 19.9.2.2. Market Analysis and Forecast by Market Taxonomy 19.9.2.2.1. By Material 19.9.2.2.2. By Source 19.9.2.2.3. By Printing Modality 19.9.2.2.4. By Application 19.9.2.2.5. By Organ/Human Tissue 19.9.2.2.6. By End User 19.9.3. Italy Bioinks Market 19.9.3.1. Introduction 19.9.3.2. Market Analysis and Forecast by Market Taxonomy 19.9.3.2.1. By Material 19.9.3.2.2. By Source 19.9.3.2.3. By Printing Modality 19.9.3.2.4. By Application 19.9.3.2.5. By Organ/Human Tissue 19.9.3.2.6. By End User 19.9.4. Spain Bioinks Market 19.9.4.1. Introduction 19.9.4.2. Market Analysis and Forecast by Market Taxonomy 19.9.4.2.1. By Material 19.9.4.2.2. By Source 19.9.4.2.3. By Printing Modality 19.9.4.2.4. By Application 19.9.4.2.5. By Organ/Human Tissue 19.9.4.2.6. By End User 19.9.5. U.K. Bioinks Market 19.9.5.1. Introduction 19.9.5.2. Market Analysis and Forecast by Market Taxonomy 19.9.5.2.1. By Material 19.9.5.2.2. By Source 19.9.5.2.3. By Printing Modality 19.9.5.2.4. By Application 19.9.5.2.5. By Organ/Human Tissue 19.9.5.2.6. By End User 19.9.6. BENELUX Bioinks Market 19.9.6.1. Introduction 19.9.6.2. Market Analysis and Forecast by Market Taxonomy 19.9.6.2.1. By Material 19.9.6.2.2. By Source 19.9.6.2.3. By Printing Modality 19.9.6.2.4. By Application 19.9.6.2.5. By Organ/Human Tissue 19.9.6.2.6. By End User 19.9.7. Russia Bioinks Market 19.9.7.1. Introduction 19.9.7.2. Market Analysis and Forecast by Market Taxonomy 19.9.7.2.1. By Material 19.9.7.2.2. By Source 19.9.7.2.3. By Printing Modality 19.9.7.2.4. By Application 19.9.7.2.5. By Organ/Human Tissue 19.9.7.2.6. By End User 19.9.8. Nordic Countries Bioinks Market 19.9.8.1. Introduction 19.9.8.2. Market Analysis and Forecast by Market Taxonomy 19.9.8.2.1. By Material 19.9.8.2.2. By Source 19.9.8.2.3. By Printing Modality 19.9.8.2.4. By Application 19.9.8.2.5. By Organ/Human Tissue 19.9.8.2.6. By End User 20. South Asia Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 20.4.1. By Country 20.4.1.1. India 20.4.1.2. Thailand 20.4.1.3. Indonesia 20.4.1.4. Malaysia 20.4.1.5. Rest of South Asia 20.4.2. By Material 20.4.3. By Source 20.4.4. By Printing Modality 20.4.5. By Application 20.4.6. By Organ/Human Tissue 20.4.7. By End User 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Material 20.5.3. By Source 20.5.4. By Printing Modality 20.5.5. By Application 20.5.6. By Organ/Human Tissue 20.5.7. By End User 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Market Trends 20.9. Country Level Analysis & Forecast 20.9.1. India Bioinks Market 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Material 20.9.1.2.2. By Source 20.9.1.2.3. By Printing Modality 20.9.1.2.4. By Application 20.9.1.2.5. By Organ/Human Tissue 20.9.1.2.6. By End User 20.9.2. Indonesia Bioinks Market 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Material 20.9.2.2.2. By Source 20.9.2.2.3. By Printing Modality 20.9.2.2.4. By Application 20.9.2.2.5. By Organ/Human Tissue 20.9.2.2.6. By End User 20.9.3. Malaysia Bioinks Market 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Material 20.9.3.2.2. By Source 20.9.3.2.3. By Printing Modality 20.9.3.2.4. By Application 20.9.3.2.5. By Organ/Human Tissue 20.9.3.2.6. By End User 20.9.4. Thailand Bioinks Market 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Material 20.9.4.2.2. By Source 20.9.4.2.3. By Printing Modality 20.9.4.2.4. By Application 20.9.4.2.5. By Organ/Human Tissue 20.9.4.2.6. By End User 21. East Asia Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 21.1. Introduction 21.2. Pricing Analysis 21.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 21.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 21.4.1. By Country 21.4.1.1. China 21.4.1.2. Japan 21.4.1.3. South Korea 21.4.2. By Material 21.4.3. By Source 21.4.4. By Printing Modality 21.4.5. By Application 21.4.6. By Organ/Human Tissue 21.4.7. By End User 21.5. Market Attractiveness Analysis 21.5.1. By Country 21.5.2. By Material 21.5.3. By Source 21.5.4. By Printing Modality 21.5.5. By Application 21.5.6. By Organ/Human Tissue 21.5.7. By End User 21.6. Key Market Participants - Intensity Mapping 21.7. Drivers and Restraints - Impact Analysis 21.8. Market Trends 21.9. Country Level Analysis & Forecast 21.9.1. China Bioinks Market 21.9.1.1. Introduction 21.9.1.2. Market Analysis and Forecast by Market Taxonomy 21.9.1.2.1. By Material 21.9.1.2.2. By Source 21.9.1.2.3. By Printing Modality 21.9.1.2.4. By Application 21.9.1.2.5. By Organ/Human Tissue 21.9.1.2.6. By End User 21.9.2. Japan Bioinks Market 21.9.2.1. Introduction 21.9.2.2. Market Analysis and Forecast by Market Taxonomy 21.9.2.2.1. By Material 21.9.2.2.2. By Source 21.9.2.2.3. By Printing Modality 21.9.2.2.4. By Application 21.9.2.2.5. By Organ/Human Tissue 21.9.2.2.6. By End User 21.9.3. South Korea Bioinks Market 21.9.3.1. Introduction 21.9.3.2. Market Analysis and Forecast by Market Taxonomy 21.9.3.2.1. By Material 21.9.3.2.2. By Source 21.9.3.2.3. By Printing Modality 21.9.3.2.4. By Application 21.9.3.2.5. By Organ/Human Tissue 21.9.3.2.6. By End User 22. Oceania Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 22.1. Introduction 22.2. Pricing Analysis 22.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 22.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 22.4.1. By Country 22.4.1.1. Australia 22.4.1.2. New Zealand 22.4.2. By Material 22.4.3. By Source 22.4.4. By Printing Modality 22.4.5. By Application 22.4.6. By Organ/Human Tissue 22.4.7. By End User 22.5. Market Attractiveness Analysis 22.5.1. By Country 22.5.2. By Material 22.5.3. By Source 22.5.4. By Printing Modality 22.5.5. By Application 22.5.6. By Organ/Human Tissue 22.5.7. By End User 22.6. Key Market Participants - Intensity Mapping 22.7. Drivers and Restraints - Impact Analysis 22.8. Market Trends 22.9. Country Level Analysis & Forecast 22.9.1. Australia Bioinks Market 22.9.1.1. Introduction 22.9.1.2. Market Analysis and Forecast by Market Taxonomy 22.9.1.2.1. By Material 22.9.1.2.2. By Source 22.9.1.2.3. By Printing Modality 22.9.1.2.4. By Application 22.9.1.2.5. By Organ/Human Tissue 22.9.1.2.6. By End User 22.9.2. New Zealand Bioinks Market 22.9.2.1. Introduction 22.9.2.2. Market Analysis and Forecast by Market Taxonomy 22.9.2.2.1. By Material 22.9.2.2.2. By Source 22.9.2.2.3. By Printing Modality 22.9.2.2.4. By Application 22.9.2.2.5. By Organ/Human Tissue 22.9.2.2.6. By End User 23. Middle East and Africa (MEA) Bioinks Market Analysis 2017–2021 and Forecast 2022–2032 23.1. Introduction 23.2. Pricing Analysis 23.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2017–2021 23.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022–2032 23.4.1. By Country 23.4.1.1. GCC Countries 23.4.1.2. Turkey 23.4.1.3. South Africa 23.4.1.4. Rest of Middle East and Africa 23.4.2. By Material 23.4.3. By Source 23.4.4. By Printing Modality 23.4.5. By Application 23.4.6. By Organ/Human Tissue 23.4.7. By End User 23.5. Market Attractiveness Analysis 23.5.1. By Country 23.5.2. By Material 23.5.3. By Source 23.5.4. By Printing Modality 23.5.5. By Application 23.5.6. By Organ/Human Tissue 23.5.7. By End User 23.6. Key Market Participants - Intensity Mapping 23.7. Drivers and Restraints - Impact Analysis 23.8. Country Level Analysis & Forecast 23.8.1. GCC Countries Bioinks Market 23.8.1.1. Introduction 23.8.1.2. Market Analysis and Forecast by Market Taxonomy 23.8.1.2.1. By Material 23.8.1.2.2. By Source 23.8.1.2.3. By Printing Modality 23.8.1.2.4. By Application 23.8.1.2.5. By Organ/Human Tissue 23.8.1.2.6. By End User 23.8.2. Turkey Bioinks Market 23.8.2.1. Introduction 23.8.2.2. Market Analysis and Forecast by Market Taxonomy 23.8.2.2.1. By Material 23.8.2.2.2. By Source 23.8.2.2.3. By Printing Modality 23.8.2.2.4. By Application 23.8.2.2.5. By Organ/Human Tissue 23.8.2.2.6. By End User 23.8.3. South Africa Bioinks Market 23.8.3.1. Introduction 23.8.3.2. Market Analysis and Forecast by Market Taxonomy 23.8.3.2.1. By Material 23.8.3.2.2. By Source 23.8.3.2.3. By Printing Modality 23.8.3.2.4. By Application 23.8.3.2.5. By Organ/Human Tissue 23.8.3.2.6. By End User 24. Market Structure Analysis 24.1. Market Analysis by Tier of Companies 24.2. Market Share Analysis of Top Players 24.3. Market Concentration 24.4. Market Presence Analysis 24.4.1. Regional Footprint Analysis 24.4.2. Product Footprint Analysis 24.4.3. Channel Footprint Analysis 25. Competition Analysis 25.1. Competition Dashboard 25.2. Competition Benchmarking 25.3. Competition Deep Dive 25.3.1. (BICO GROUP AB) CELLINK 25.3.1.1. Overview 25.3.1.2. Product Portfolio 25.3.1.3. Key Financials 25.3.1.4. SWOT Analysis 25.3.1.5. Sales Footprint 25.3.1.6. Strategy Overview 25.3.1.7. Key Developments 25.3.1.7.1. Marketing Strategies 25.3.1.7.2. Product Strategies 25.3.1.7.3. Channel Strategies 25.3.2. Merck KGaA 25.3.2.1. Overview 25.3.2.2. Product Portfolio 25.3.2.3. Key Financials 25.3.2.4. SWOT Analysis 25.3.2.5. Sales Footprint 25.3.2.6. Strategy Overview 25.3.2.7. Key Developments 25.3.2.7.1. Marketing Strategies 25.3.2.7.2. Product Strategies 25.3.2.7.3. Channel Strategies 25.3.3. Allevi, Inc. 25.3.3.1. Overview 25.3.3.2. Product Portfolio 25.3.3.3. Key Financials 25.3.3.4. SWOT Analysis 25.3.3.5. Sales Footprint 25.3.3.6. Strategy Overview 25.3.3.7. Key Developments 25.3.3.7.1. Marketing Strategies 25.3.3.7.2. Product Strategies 25.3.3.7.3. Channel Strategies 25.3.4. TheWell Bioscience Inc. 25.3.4.1. Overview 25.3.4.2. Product Portfolio 25.3.4.3. Key Financials 25.3.4.4. SWOT Analysis 25.3.4.5. Sales Footprint 25.3.4.6. Strategy Overview 25.3.4.7. Key Developments 25.3.4.7.1. Marketing Strategies 25.3.4.7.2. Product Strategies 25.3.4.7.3. Channel Strategies 25.3.5. CollPlant Biotechnologies Ltd. 25.3.5.1. Overview 25.3.5.2. Product Portfolio 25.3.5.3. Key Financials 25.3.5.4. SWOT Analysis 25.3.5.5. Sales Footprint 25.3.5.6. Strategy Overview 25.3.5.7. Key Developments 25.3.5.7.1. Marketing Strategies 25.3.5.7.2. Product Strategies 25.3.5.7.3. Channel Strategies 25.3.6. UPM Biomedicals 25.3.6.1. Overview 25.3.6.2. Product Portfolio 25.3.6.3. Key Financials 25.3.6.4. SWOT Analysis 25.3.6.5. Sales Footprint 25.3.6.6. Strategy Overview 25.3.6.7. Key Developments 25.3.6.7.1. Marketing Strategies 25.3.6.7.2. Product Strategies 25.3.6.7.3. Channel Strategies 25.3.7. Brinter® 25.3.7.1. Overview 25.3.7.2. Product Portfolio 25.3.7.3. Key Financials 25.3.7.4. SWOT Analysis 25.3.7.5. Sales Footprint 25.3.7.6. Strategy Overview 25.3.7.7. Key Developments 25.3.7.7.1. Marketing Strategies 25.3.7.7.2. Product Strategies 25.3.7.7.3. Channel Strategies 25.3.8. Foldink 25.3.8.1. Overview 25.3.8.2. Product Portfolio 25.3.8.3. Key Financials 25.3.8.4. SWOT Analysis 25.3.8.5. Sales Footprint 25.3.8.6. Strategy Overview 25.3.8.7. Key Developments 25.3.8.7.1. Marketing Strategies 25.3.8.7.2. Product Strategies 25.3.8.7.3. Channel Strategies 25.3.9. Black Drop Biodrucker Gmb 25.3.9.1. Overview 25.3.9.2. Product Portfolio 25.3.9.3. Key Financials 25.3.9.4. SWOT Analysis 25.3.9.5. Sales Footprint 25.3.9.6. Strategy Overview 25.3.9.7. Key Developments 25.3.9.7.1. Marketing Strategies 25.3.9.7.2. Product Strategies 25.3.9.7.3. Channel Strategies 25.3.10. TissueLabs 25.3.10.1. Overview 25.3.10.2. Product Portfolio 25.3.10.3. Key Financials 25.3.10.4. SWOT Analysis 25.3.10.5. Sales Footprint 25.3.10.6. Strategy Overview 25.3.10.7. Key Developments 25.3.10.7.1. Marketing Strategies 25.3.10.7.2. Product Strategies 25.3.10.7.3. Channel Strategies 25.3.11. Axolotl Biosciences 25.3.11.1. Overview 25.3.11.2. Product Portfolio 25.3.11.3. Key Financials 25.3.11.4. SWOT Analysis 25.3.11.5. Sales Footprint 25.3.11.6. Strategy Overview 25.3.11.7. Key Developments 25.3.11.7.1. Marketing Strategies 25.3.11.7.2. Product Strategies 25.3.11.7.3. Channel Strategies 25.3.12. Manchester BIOGEL 25.3.12.1. Overview 25.3.12.2. Product Portfolio 25.3.12.3. Key Financials 25.3.12.4. SWOT Analysis 25.3.12.5. Sales Footprint 25.3.12.6. Strategy Overview 25.3.12.7. Key Developments 25.3.12.7.1. Marketing Strategies 25.3.12.7.2. Product Strategies 25.3.12.7.3. Channel Strategies 25.3.13. 3DPL 25.3.13.1. Overview 25.3.13.2. Product Portfolio 25.3.13.3. Key Financials 25.3.13.4. SWOT Analysis 25.3.13.5. Sales Footprint 25.3.13.6. Strategy Overview 25.3.13.7. Key Developments 25.3.13.7.1. Marketing Strategies 25.3.13.7.2. Product Strategies 25.3.13.7.3. Channel Strategies 25.3.14. Humabiologics 25.3.14.1. Overview 25.3.14.2. Product Portfolio 25.3.14.3. Key Financials 25.3.14.4. SWOT Analysis 25.3.14.5. Sales Footprint 25.3.14.6. Strategy Overview 25.3.14.7. Key Developments 25.3.14.7.1. Marketing Strategies 25.3.14.7.2. Product Strategies 25.3.14.7.3. Channel Strategies 26. Assumptions and Acronyms Used 27. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Persistence Market Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
